文献
J-GLOBAL ID:201802284073508483
整理番号:18A0921212
上皮成長因子受容体を過剰発現させる可能性がある進行性固形腫瘍患者におけるデパツキシズマブ・マホドチン(ABT-414)の有効性と安全性の結果【JST・京大機械翻訳】
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
著者 (19件):
Goss Glenwood D.
(The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Ontario, Canada)
,
Vokes Everett E.
(Department of Medicine, University of Chicago, Chicago, Illinois)
,
Gordon Michael S.
(HonorHealth Research Institute, Scottsdale, Arizona)
,
Gandhi Leena
(New York University Perlmutter Cancer Center, NYU Health, New York, New York)
,
Papadopoulos Kyriakos P.
(South Texas Accelerated Research Therapeutics, San Antonio, Texas)
,
Rasco Drew W.
(South Texas Accelerated Research Therapeutics, San Antonio, Texas)
,
Fischer JuDee S.
(AbbVie, Inc, North Chicago, Illinois)
,
Chu Katharine L.
(AbbVie, Inc, North Chicago, Illinois)
,
Ames William W.
(AbbVie, Inc, North Chicago, Illinois)
,
Mittapalli Rajendar K.
(AbbVie, Inc, North Chicago, Illinois)
,
Lee Ho-Jin
(AbbVie, Inc, North Chicago, Illinois)
,
Zeng Jiewei
(AbbVie, Inc, North Chicago, Illinois)
,
Roberts-Rapp Lisa A.
(AbbVie, Inc, North Chicago, Illinois)
,
Loberg Lise I.
(AbbVie, Inc, North Chicago, Illinois)
,
Ansell Peter J.
(AbbVie, Inc, North Chicago, Illinois)
,
Reilly Edward B.
(AbbVie, Inc, North Chicago, Illinois)
,
Ocampo Christopher J.
(AbbVie, Inc, North Chicago, Illinois)
,
Holen Kyle D.
(AbbVie, Inc, North Chicago, Illinois)
,
Tolcher Anthony W.
(South Texas Accelerated Research Therapeutics, San Antonio, Texas)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
124
号:
10
ページ:
2174-2183
発行年:
2018年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)